300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Oman
New Zealand
Cameroon
Colombia
Australia
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Moldova
Malawi
Seychelles
Botswana
United Kingdom
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Canada
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Angel Investors in Europe (July 2026)

The most active angel investors investing in Europe Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
30 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Nadav Rosenberg
Angel
5 United Kingdom, France, Israel Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Software $850k–$19M
Stefano Bernardi
Angel
5 Italy, United Kingdom, France Seed, Pre-Seed Software, Biotechnology, Artificial Intelligence $100k–$45M
Sake Bosch
Angel
4 The Netherlands, France, Israel Seed, Series A, Series B Software, E-Commerce, Biotechnology $1.9M–$77M
Charlie Songhurst
Angel
4 United Kingdom, United States, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $500k–$8M
Milad Alucozai
Angel
4 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $110k–$60M
Bernard Majoie
Angel
4 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care $1.3M–$1.4M
Andrea Dusi
Angel
4 Italy, United States, United Kingdom Seed, Pre-Seed, Angel Biotechnology, Health Care, FinTech $150k–$6M
Annie Vereecken
Angel
4 Belgium Seed, Series A Medical, Biotechnology, Hospital $2M–$27M
Per Falholt
Angel
4 Denmark Pre-Seed, Series A, Seed Biotechnology, Robotics, Biopharma $5.9M–$20M
Peder Nielsen
Angel
3 United Kingdom Seed, Convertible Note Biotechnology, Machine Learning
John Purdy
Angel
3 Ireland Seed, Pre-Seed Software, FinTech, Medical $576k–$1.1M
Romain Sautrau
Angel
3 France, Denmark Series A, Seed, Pre-Seed Biotechnology, Agriculture, Video $1.1M–$12M
Inaki Berenguer
Angel
3 Spain, United States, United Kingdom Seed, Angel, Pre-Seed FinTech, E-Commerce, Financial Services $233k–$9M
Paul Wicks
Angel
3 United Kingdom, United States, Japan Seed, Pre-Seed, Series A Software, Wellness, E-Commerce $539k–$11M
Ian Hogarth
Angel
3 United Kingdom, United States, Germany Seed, Series A, Pre-Seed Software, Artificial Intelligence, E-Commerce $668k–$28M
Darrin Disley
Angel
3 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $458k–$3.7M
David Helgason
Angel
3 United States, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Information Technology $1k–$30M
Taavet Hinrikus
Angel
3 United Kingdom, United States, Estonia Seed, Series A, Series B FinTech, Software, Financial Services $1M–$50M
Jude Gomila
Angel
3 United States, United Kingdom, India Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $70k–$5M
Jeff Dean
Angel
3 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$60M
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
DrPano Kroko Churchill
Angel
3 United Kingdom Angel, Series A Health Care, Therapeutics, Biotechnology $150k–$458k
Schnidar Harald
Angel
3 Austria Seed, Angel, Pre-Seed mHealth, Software, Biopharma
Nicholas Francis
Angel
3 Denmark, United States Seed, Series A SaaS, Robotics, Software $854k–$8.1M
Pierre Drion
Angel
3 Belgium Series A, Series B Biotechnology, Health Care, Life Science $8.8M–$26M
Barbara Castellano
Angel
2 Italy Pre-Seed Health Care, Biotechnology, Medical Device
André-Jacques Auberton-Hervé
Angel
2 France Seed, Series A Medical, Biotechnology
Carsten Maschmeyer
Angel
2 Germany, Austria, Switzerland Seed, Angel, Series A Software, Information Technology, Apps
Jon Oringer
Angel
2 United States, France, United Kingdom Seed, Pre-Seed Software, Information Technology, E-Commerce
Gilad Engel
Angel
2 France, Israel, United Kingdom Seed, Pre-Seed Hardware, Analytics, Biotechnology
Nicolas Douay
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology
Tim Dempsey
Angel
2 United Kingdom Seed, Series A Software, SaaS, Financial Services $962k–$13M
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note FinTech, Finance, Life Science
Pratima Aiyagari
Angel
2 United Kingdom, France, Germany Seed, Pre-Seed, Series A SaaS, Software, Analytics $982k–$12M
Paul Forster
Angel
2 United Kingdom, Germany, United States Seed, Series A, Pre-Seed Software, FinTech, Financial Services $1.1M–$18M
Bruce Linton
Angel
2 Canada, United States, Denmark Seed, Post-IPO Equity, Pre-Seed Health Care, Cannabis, Biotechnology
Andreas Ehn
Angel
2 Sweden, United States, Germany Seed, Angel, Pre-Seed Software, Internet, Financial Services $911k–$7.7M
Andrew Nutter
Angel
2 France, United Kingdom, United States Seed, Pre-Seed Software, SaaS, FinTech $550k–$4.9M
Marton Szoke
Angel
2 Hungary, Czech Republic, Switzerland Series A, Seed, Pre-Seed Software, Information Technology, E-Commerce $1.7M–$3M
Fabio Mondini de Focatiis
Angel
2 Italy, France, United Kingdom Seed, Pre-Seed, Equity Crowdfunding E-Commerce, Retail, Information Technology $329k–$2.9M
Damien Lane
Angel
2 United Kingdom, United States, Ireland Seed, Pre-Seed, Series A SaaS, Software, Health Care $459k–$16M
Chris Mairs
Angel
2 United Kingdom, United States Seed, Pre-Seed, Angel Software, FinTech, Financial Services $334k–$3.7M
Serge Chiaramonte
Angel
2 United Kingdom, United States, France Seed, Pre-Seed FinTech, Financial Services, Information Technology $637k–$37M
Holger Hübner
Angel
2 Germany Seed, Pre-Seed B2B, SaaS, Audio $177k–$987k
Giampaolo Cagnin
Angel
2 Italy, Denmark Seed, Pre-Seed Biotechnology, Food and Beverage, Plant-Based Foods $4.2M–$7.6M
Vishal Gulati
Angel
2 United Kingdom, Hungary Seed, Series A, Series B Biotechnology, Biopharma, Life Science $2.1M–$30M
Leena Niemistö
Angel
2 Finland, United States Seed, Pre-Seed Health Care, Software, E-Commerce $480k–$3.2M
Nico Wittenborn
Angel
2 United States, Germany, France Seed, Series A, Series B Software, Apps, Wellness $1.6M–$88M
Hampus Jakobsson
Angel
2 Sweden, Denmark, United States Seed, Angel, Series A Health Care, Software, Artificial Intelligence $96k–$33M
Access all 50 angel investors in Europe Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 30 investments in Europe Biotechnology startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 61
  • Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 5 investments in Europe Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 5 investments in Europe Biotechnology startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $874k–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Freatic — Building the monetization layer for your alpha
  • Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Europe Biotechnology startups

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 32
  • Round size: Seed $1.9M–$9.5M; Series A $6.9M–$29M; Series B $7.1M–$77M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
  • Recupere Metals — Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting.
  • A&B Smart Materials — The A&B Smart Materials Using innovative cooling technologies to boost photovoltaic efficiency.
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 4 investments in Europe Biotechnology startups

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 191
  • Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
  • Hyphen SCS — Find and rent verified warehouses across 992+ cities in India. Compare 65,000+ listings on Hyphen SCS.
  • Structured AI — AI-powered QA/QC for construction documents. Structured catches errors before they reach the field.
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 4 investments in Europe Biotechnology startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $150k–$6.7M; Pre-Seed $110k–$5M; Series A $13M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 4 investments in Europe Biotechnology startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 5
  • Round size: Seed $1.3M–$1.4M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Andrea Dusi
Angel · Verona, Veneto, Italy · 4 investments in Europe Biotechnology startups

Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded the no-profit organization Impactscool, withthe aim to bring education on exponential technologies to Italian students and teachers. Impactscool was sold in 2025 with an exit to an Italian bank. Now his focus is manly on studying, exploring the potential of human beings, understanding true meaning of life, enjoying the passage of time. He is advisor of dozens of technological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, FinTech
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 17
  • Round size: Seed $150k–$6M; Angel $170k–$2.5M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • CitizenX — CitizenX is the world's first platform to help you find and fund places that welcome you as a citizen. Secure a safe haven and travel freely across the globe with a passport from your new home(s).
  • Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Show all investments...

Annie Vereecken
Angel · Antwerp, Antwerpen, Belgium · 4 investments in Europe Biotechnology startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$6M; Series A $8.2M–$27M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • LynxCare — Continuously improving patient outcomes with previously unavailable insights. Find out more here.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Per Falholt
Angel · Copenhagen, Hovedstaden, Denmark · 4 investments in Europe Biotechnology startups

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Biopharma
  • Stage:Pre-Seed, Series A, Seed
  • Geography: Denmark

Investor stats

  • Total investments: 5
  • Round size: Series A $5.9M–$20M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Peder Nielsen
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in Europe Biotechnology startups

Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund

Show more...

Investment focus

  • Industry: Biotechnology, Machine Learning
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Show all investments...

John Purdy
Angel · Dublin, Dublin, Ireland · 3 investments in Europe Biotechnology startups

John Purdy

Show more...

Investment focus

  • Industry: Software, FinTech, Medical
  • Stage:Seed, Pre-Seed
  • Geography: Ireland

Investor stats

  • Total investments: 5
  • Round size: Seed $576k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • dimply — The experience & engagement platform for financial enterprises.
  • Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
  • FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
Show all investments...

Romain Sautrau
Angel · Paris, Ile-de-France, France · 3 investments in Europe Biotechnology startups

Romain Sautrau is a Investment Director at Supernova Invest. Romain attended INSEAD.

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, Video
  • Stage:Series A, Seed, Pre-Seed
  • Geography: France, Denmark

Investor stats

  • Total investments: 13
  • Round size: Seed $1.4M–$2.4M; Series A $1.1M–$12M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Novolyze — Novolyze is a Food Safety company. They offer solutions to help the food industry manufacture safer food, while ensuring strong compliance with international Food Safety & Quality standards. Their research work mainly focuses on evaluating the inactivation of foodborne pathogens under different kinds of stress (heat, etc.). Based on thisexpertise, they have developed the first range of dried, ready-to-use surrogate bacteria, an innovation that allows the food industry to test the efficacy of microbial kill steps / intervention steps in real-life conditions. At Novolyze, they are at the forefront of Food Safety. Their cross-functional team of experts, mainly composed of food microbiologists and process engineers, is able to assist at multiple stages of a project. Novolyze relies on state-of-the-art infrastructures, installed in a pharmaceutical-grade environment at their R&D Center in Dijon, France.
  • Antofenol — Antofénol is a post-harvest biocontrol company that directs and develops its work on the valorization of viticultural waste. Antofénol is an innovative biotechnology start-up providing ecological eco-extraction of plant matter.
  • nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
Show all investments...

Inaki Berenguer
Angel · New York, New York, United States · 3 investments in Europe Biotechnology startups

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Show more...

Investment focus

  • Industry: FinTech, E-Commerce, Financial Services
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $500k–$9M; Angel $233k–$1M; Pre-Seed $1.2M–$2M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
  • Permisso — Bankflip is a mobile application that collects and processes income, tax, employment, and relevant data in real-time.
  • Momento — Momento is an insurtech company with the objective of revolutionizing the insurance industry in Latin America, starting with car insurance. We want to make insurance easy and accessible for the underserved population in LATAM.
Show all investments...

Paul Wicks
Angel · London, England, United Kingdom · 3 investments in Europe Biotechnology startups

Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.

Show more...

Investment focus

  • Industry: Software, Wellness, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 17
  • Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.9M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
  • Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
  • Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 3 investments in Europe Biotechnology startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 56
  • Round size: Seed $1.5M–$7.9M; Pre-Seed $668k–$7.5M; Series A $11M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Cordless — Bridging the gap between voice and text
  • Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 3 investments in Europe Biotechnology startups

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $458k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in Europe Biotechnology startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 73
  • Round size: Seed $1.1M–$8M; Pre-Seed $1k–$2.4M; Series A $4.3M–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • ScyAI — ScyAI is the developer of an autonomous risk intelligence tool designed to integrate multiple specialized agents.
  • Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

Taavet Hinrikus
Angel · London, England, United Kingdom · 3 investments in Europe Biotechnology startups

Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.

Show more...

Investment focus

  • Industry: FinTech, Software, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 127
  • Round size: Seed $1M–$7.9M; Series A $7M–$47M; Series B $23M–$50M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
  • Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
  • Entrepreneurs First — We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 3 investments in Europe Biotechnology startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 58
  • Round size: Seed $1.4M–$5M; Angel $70k–$1.3M; Pre-Seed $1M–$2.8M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Clara
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
  • Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Jeff Dean
Angel · Palo Alto, California, United States · 3 investments in Europe Biotechnology startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 101
  • Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
  • Moonlake AI — Vibe code games and worlds into existence.
  • Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
Show all investments...

Andrew Keys
Angel · 3 investments in Europe Biotechnology startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

DrPano Kroko Churchill
Angel · Seattle, Washington, United States · 3 investments in Europe Biotechnology startups

Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com

Show more...

Investment focus

  • Industry: Health Care, Therapeutics, Biotechnology
  • Stage:Angel, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Angel $150k–$458k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Show all investments...

Schnidar Harald
Angel · Vienna, Wien, Austria · 3 investments in Europe Biotechnology startups

Entrepreneur, Angel Investor, Scientist and Inventor

Show more...

Investment focus

  • Industry: mHealth, Software, Biopharma
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Austria

Investor stats

  • Total investments: 7
  • Lead/follow: 86% lead, 14% follow

Portfolio highlights

  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Show all investments...

Nicholas Francis
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in Europe Biotechnology startups

Nicholas Francis is based out of Copenhagen, Hovedstaden, and is the Founder of Francis Family Funds. Nicholas previously worked at framebunker as a Co-Founder.

Show more...

Investment focus

  • Industry: SaaS, Robotics, Software
  • Stage:Seed, Series A
  • Geography: Denmark, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $854k–$8.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Waterplan — Waterplan is a SaaS platform for companies to manage water availability in their facilities.
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 3 investments in Europe Biotechnology startups

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Round size: Series A $8.8M–$14M; Series B $18M–$26M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Barbara Castellano
Angel · Milan, Lombardia, Italy · 2 investments in Europe Biotechnology startups

Laura Iris Ferro

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Pre-Seed
  • Geography: Italy

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
  • CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Show all investments...

André-Jacques Auberton-Hervé
Angel · 2 investments in Europe Biotechnology startups

Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.

Show more...

Investment focus

  • Industry: Medical, Biotechnology
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Show all investments...

Carsten Maschmeyer
Angel · Hanover, Niedersachsen, Germany · 2 investments in Europe Biotechnology startups

Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Angel, Series A
  • Geography: Germany, Austria, Switzerland

Investor stats

  • Total investments: 78
  • Lead/follow: no public data

Portfolio highlights

  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
  • Bildungs urlauber — The goal of Bildungsurlauber.de is to make complicated topics simple. First and foremost, we assist you in locating the appropriate seminar for you by using simple filter options - regardless of whatever federal state you work in.
Show all investments...

Jon Oringer
Angel · Miami, Florida, United States · 2 investments in Europe Biotechnology startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 115
  • Lead/follow: no public data

Portfolio highlights

  • SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
  • Unsloth AI — Open source fine-tuning & reinforcment learning (RL) for gpt-oss, Llama 4, DeepSeek-R1 and Qwen3 LLMs! Beginner friendly.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Gilad Engel
Angel · 2 investments in Europe Biotechnology startups

Gilad Engel

Show more...

Investment focus

  • Industry: Hardware, Analytics, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: France, Israel, United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Joe — Joe is an financial service that reimburses and allows ALL expenses to be paid in several installments.
  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Fourier Optics — Fourier optics creates meta-surface based optical systems for Augmented Reality glasses
Show all investments...

Nicolas Douay
Angel · Paris, Ile-de-France, France · 2 investments in Europe Biotechnology startups

Previously cofounder @ Keldoc - currently early stage investor @ Better Angle

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 57
  • Lead/follow: no public data

Portfolio highlights

  • Samp — Whatever the scale, age, or number of facilities, Shared Reality helps industrial operators accelerate their digital twin programs in an affordable and accessible way.
  • Ambler — Ambler is a startup founded in 2018 by experts in digital and so-called "marketplace" models 100% French, the company enjoys the support of public authorities (Wilco-ex Scientipôle) and the support of prestigious private investors , including Partech, Idinvest Partners, Kima Ventures.The startup is developing technologies to help matchthe supply and demand of medical transports. It aggregates, thanks to win-win partnerships, a considerable fleet of vehicles and offers unparalleled deliverability for contractors. Ambler is the only solution capable, nationwide, of absorbing the constant growth of health transport flows induced by demographic and regulatory factors (reform of regional hospital groups).
  • Lalilo — Sign up and invite parents remotely for home access to phonics and reading lessons.
Show all investments...

Tim Dempsey
Angel · 2 investments in Europe Biotechnology startups

Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.

Show more...

Investment focus

  • Industry: Software, SaaS, Financial Services
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 18
  • Round size: Seed $962k–$2.5M; Series A $6.4M–$13M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
  • PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
  • AeroCloud — Reinvent airport management with cloud-based software that enhances efficiency, unifies operations, and helps airports deliver a seamless, people-first experience.
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in Europe Biotechnology startups

Robert Kopple

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Pratima Aiyagari
Angel · London, England, United Kingdom · 2 investments in Europe Biotechnology startups

Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability.

Show more...

Investment focus

  • Industry: SaaS, Software, Analytics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Germany

Investor stats

  • Total investments: 11
  • Round size: Seed $1.2M–$8.3M; Pre-Seed $982k–$1.2M; Series A $7M–$12M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Treblle — Treblle is a lightweight SDK that helps Engineering and DevOps teams build, ship & maintain REST based APIs faster
  • Mindflow — Mindflow is a No-Code & Agentic Automation & Orchestration Platform that enables all Enterprise Cyber IT Professionals to Automate Mundane tasks and to deploy AI Agents at scale.
Show all investments...

Paul Forster
Angel · Cambridge, Massachusetts, United States · 2 investments in Europe Biotechnology startups

Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 80
  • Round size: Seed $1.1M–$7.2M; Pre-Seed $1.1M–$3.5M; Series A $3.9M–$18M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Oraion — Your single source of truth for enterprise data
  • Capsa AI — Providing next-generation investors with a competitive edge.
  • Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
Show all investments...

Bruce Linton
Angel · Ottawa, Ontario, Canada · 2 investments in Europe Biotechnology startups

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

Show more...

Investment focus

  • Industry: Health Care, Cannabis, Biotechnology
  • Stage:Seed, Post-IPO Equity, Pre-Seed
  • Geography: Canada, United States, Denmark

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Martello Technologies — Prioritize and resolve performance problems and optimize the Microsoft 365 and Teams user experience with Martello Vantage DX.
Show all investments...

Andreas Ehn
Angel · San Francisco, California, United States · 2 investments in Europe Biotechnology startups

Andreas is working on a service that will connect people, time and places on the web. He also works as an independent consultant helping other startups with product strategy, technical infrastructure, scalability and recruiting as well as financial companies (venture capital and private equity) with technical due diligence and in other advisorroles.He was CTO at Spotify from the launch of the company in August 2006 until November 2009. Before that he worked at Stardoll as an engineer and project manager.

Show more...

Investment focus

  • Industry: Software, Internet, Financial Services
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Sweden, United States, Germany

Investor stats

  • Total investments: 18
  • Round size: Seed $911k–$7.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Visor — Spatial computing designed for work.
  • Mavenoid — Mavenoid is the only product support automation platform built for complex products and devices. Using our unique AI, we solve problems too complex for chatbots
  • Red Flag — Red Flag develops an automated accounting, expenses, and invoicing platform for SMEs.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in Europe Biotechnology startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
  • Applikate Technologies — Applikate Technologies is a hardware and software company that develops a fully automated histology platform with integrated digital imaging. The platform automates the pathology workflow, reducing processing time, lowering cost, and improving image quality, which reduces the risk of misdiagnosis.
Show all investments...

Marton Szoke
Angel · Budapest, Budapest, Hungary · 2 investments in Europe Biotechnology startups

An entrepreneur and investor with a business background and solid technical experience. Founded several startups, the latest being Indextools, a software company specializing in enterprise on-demand web analytics software. In April 2008 Indextools got acquired by Yahoo! Inc. At the time of the acquisition, Indextools was recognized as one of thetop five web analytics vendors world-wide by Forrester / Jupiter Research. Mr. Szőke served at Yahoo for three years to lead integration efforts and to realign Indextools’ business model.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Series A, Seed, Pre-Seed
  • Geography: Hungary, Czech Republic, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Series A $1.7M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Omixon — Omixon is a biotechnology company that specializes in high-resolution HLA genotyping.
  • Logiscool — International franchise network teaching kids programming
  • Tresorit — Tresorit is a cloud-based, secure file synchronising software, specifically designed to share confidential data of business users. The software is suitable for making shared directories in a way that the files in the directories are encrypted before uploaded and the encrypted file will get into the cloud. When downloading the file from the cloud itis decryptable only when permitted by the owner. Other users are unable to decode its contents. The special feature of Tresorit is that the encrypted contents are shareable without re-encryption and that sharing is reversible by permission revocation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Fabio Mondini de Focatiis
Angel · Paris, Ile-de-France, France · 2 investments in Europe Biotechnology startups

Venture Partner, Eurazeo InvestmentInternational Venture Capitalist, Business Angel and SVP with >20 years experience in >20 countries, with a successful track as VC, BA and Entrepreneur in a truly global environment. Fabio is a Venture Partner in Eurazeo Investment, following their acquisition of IDINVEST Partners, a leading Europeanprivate equity firm with >9B€ AUM, focusing on Venture Capital investments in Italy across sectors and in the Smart City sector (Energy, Cleantech, Eco-mobility) worldwide. Fabio is the Founder and CEO of growth Capital, the leading Italian investment banking focusing on advising innovative, fast-growing companies on fund raising and M&A. Fabio is also an active Business Angel, with a personal portfolio of more than 30 startups. a Member of the Investment Committee of Lazio Innova. Previously Fabio has been a Senior Advisor in the European Investment Fund (EIF), leading the joint efforts of EIF and Cassa Depositi e Prestiti (CDP) to establish TT Investment Funds in Italy to develop its ecosystem for Innovation. Before entering the Private Equity sector, Fabio has lead Soitec Solar Division sale after it has increased its revenues from ~2M€ to >40M€ and achieved the world record of PV Module Efficiency and Solar Cell Efficiency. He had earlier founded and lead RenEn Renewable Energy to a leading renewable energy consulting firm. Earlier Fabio has been in McKinsey, ENEL and Russell Reynolds. In ENEL, Fabio has been Head of Integration, Head of International Management, Head of HR and Organisation and member of the Board of various international companies. Fabio received his M.S. degree in Civil and Environmental Engineering from M.I.T. and his M.B.A. from INSEAD. He is fluent in English, Italian, French and Spanish.

Show more...

Investment focus

  • Industry: E-Commerce, Retail, Information Technology
  • Stage:Seed, Pre-Seed, Equity Crowdfunding
  • Geography: Italy, France, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $329k–$2.2M; Equity Crowdfunding $1.4M–$2.9M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Icohup — The aim of Icohup is the development of pollution sensors with high performance yet low costs.
  • Yobs — Record your interviews, accelerate candidate review, coach recruiters and build a fair and rigorous hiring process.
  • Keyless — Reverify and authenticate your users in a glance, without storing biometric data. PingOne Recognize delivers private, fraud-resistant biometric authentication.
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 2 investments in Europe Biotechnology startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: SaaS, Software, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 38
  • Round size: Seed $459k–$3.1M; Pre-Seed $605k–$1M; Series A $3.2M–$16M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
  • IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Show all investments...

Chris Mairs
Angel · London, England, United Kingdom · 2 investments in Europe Biotechnology startups

Chris Mairs - Venture Partner @ Entrepreneurs First

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $655k–$3.7M; Angel $334k–$707k; Pre-Seed $900k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
  • Incard — Welcome to the world's first payment solution designed exclusively for e-commerce, entrepreneurs, dropshippers and influencers. Join our waitlist now.
  • Briefcase — Automate your accounting workflows with AI
Show all investments...

Serge Chiaramonte
Angel · London, England, United Kingdom · 2 investments in Europe Biotechnology startups

Serge Chiaramonte

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 59
  • Round size: Seed $1.2M–$4.9M; Pre-Seed $637k–$37M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Desia — Desia provides advanced AI applications for productivity, automation, and analytics for financial services.
  • Tranched — Introducing real-time on-chain securitisation. Fintech Lenders and Professional Investors can now launch an institutional-grade transaction up to 90% faster than before.
  • Juno — Meet Juno, a workplace wellbeing programme that you control.
Show all investments...

Holger Hübner
Angel · Hamburg, Hamburg, Germany · 2 investments in Europe Biotechnology startups

Holger Hübner

Show more...

Investment focus

  • Industry: B2B, SaaS, Audio
  • Stage:Seed, Pre-Seed
  • Geography: Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Show all investments...

Giampaolo Cagnin
Angel · Parma, Emilia-Romagna, Italy · 2 investments in Europe Biotechnology startups

Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Plant-Based Foods
  • Stage:Seed, Pre-Seed
  • Geography: Italy, Denmark

Investor stats

  • Total investments: 3
  • Round size: Seed $4.2M–$7.6M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
  • Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.
Show all investments...

Vishal Gulati
Angel · London, England, United Kingdom · 2 investments in Europe Biotechnology startups

Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 8
  • Round size: Seed $3.2M–$8M; Series A $2.1M–$12M; Series B $6.8M–$30M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
  • Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
  • Turbine — Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.
Show all investments...

Leena Niemistö
Angel · Helsinki, Southern Finland, Finland · 2 investments in Europe Biotechnology startups

Leena Niemistö

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: Finland, United States

Investor stats

  • Total investments: 19
  • Round size: Seed $480k–$3.2M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
  • ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
Show all investments...

Nico Wittenborn
Angel · New York, New York, United States · 2 investments in Europe Biotechnology startups

Nico Wittenborn is an Investor at Adjacent.

Show more...

Investment focus

  • Industry: Software, Apps, Wellness
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, France

Investor stats

  • Total investments: 42
  • Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Niantic — Niantic focuses on developing games that encourage outdoor activity and social engagement. It aims to create products for movement, exploration, and face-to-face social interaction. Its notable products include Ingress and Pokémon GO.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Sunnyside — Sunnyside is the #1 alcohol moderation app helping 600,000+ people drink less through tracking, coaching, and optional naltrexone via telehealth. Start your free 15-day trial.
Show all investments...

Hampus Jakobsson
Angel · Malmö, Skane Lan, Sweden · 2 investments in Europe Biotechnology startups

Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.

Show more...

Investment focus

  • Industry: Health Care, Software, Artificial Intelligence
  • Stage:Seed, Angel, Series A
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 43
  • Round size: Seed $310k–$5.3M; Angel $96k–$1.2M; Series A $2.3M–$33M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
  • Mojo — Clinical-grade, AI-powered sperm analysis from the comfort of home. Test your sperm count, motility, morphology and much more with the Mojo kit. Check your fertility from home at low cost - without the need for clinic visits and awkward waiting rooms.
  • Volta Greentech — Battling global warming by reducing methane emissions from cows
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in Europe Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists